In an era marked by remarkable advancements in medical diagnostics, the global minimal residual disease (MRD) testing market is poised for unprecedented growth. Projections suggest that by 2031, the ...

Driven EcosystemsDublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Product Type (Instruments, Reagents & Kits, Software & Services), Test Techniques (Flow ...

The North American minimal residual disease (MRD) testing market is poised for substantial growth in the coming years. With a projected annual increase of 11.1% throughout the forecast period, ...

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Product Type (Instruments, Reagents & Kits, Software & Services), Test Techniques (Flow Cytometry ...

Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible ...

It is important for practicing hematopathologists to understand the prognostic and therapeutic significance of the MRD result and be aware of the advances made in this field. Flow Cytometry is a ...

including CD69 upregulation measured by flow cytometry and cytokine secretion measured by immunoassays. As we show on Slide 11, MRD-6160 achieved dose dependent VAV1 degradation in peripheral ...